摘要
目的:探讨血清CA199、CA50联合检测对胰腺癌诊断及预后的价值。方法:分析潮州市医院2010年1月至2011年3月间收治的胰腺癌患者以及健康体检者各42例的临床资料,比较两组之间CA199、CA50水平,研究CA199、CA50联合检测的价值。结果:观察组CA199和CA50水平均明显高于对照组(P<0.05);观察组患者在肿瘤可切除性和分期不同的情况下CA199、CA50水平差异显著(P<0.05);CA199和CA50联合检测能够提高准确性;CA199、CA50水平可作为患者术后中位生存期的判定标准。结论:血清CA199、CA50联合检测能够提供重要的诊断和预后价值,具有很高的临床应用价值。
Objective： To explore combined detection of serum CAl99, CA50 levels in patients with pancreatic cancer and prognostic value. Method： Analyzed clinical data of 42 cases pancreatic remission patients and 42 cases healthy subjects of our hospital, from Jan. 2010 to Mar. 20ll, CA199, CA50 were com- pared between the two groups, researched value of combined detection of serum CA199, CA50. Result： CA199 and CA50 of the observation group were significantly higher than control group { P〈0.05 ） ;The differ- ence of CA199 and CA50 were significant when tumor of observation group were different in resectability and staging{ P〈0.05 ） ; combined detection of serum CA199, CA50 can improve accuracy; CA199, CA50 levels can be criteria for median survival time of postoperative patients. Conclusion： Combined detection of serum CA199, CA50 levels can provide important diagnostic and prognostic value, have high clinical value.
出处
《河北医学》
CAS
2013年第6期838-841,共4页
Hebei Medicine
